Presentations

Friday, August 1, 2014

Alchemia has held an investor briefing over lunch in Melbourne. The slides are presented herein, with presentations by Thomas Liquard, Peter Gibbs MD and Dr Tracey Brown.

Monday, June 2, 2014

The Company has provided a short investor update presentation on the quarterly sales and profit share for fondaparinux from Dr Reddy's Laboratory.

Tuesday, April 8, 2014

Alchemia today announced it will be presenting proprietary data at the American Association for Cancer Research (AACR) Meeting 2014. The poster presentation is entitled "The Characterisation of Hyaluronan-Related Enzymes in Breast Cancer Cell Subpopulations"

Thursday, March 13, 2014

Alchemia CEO, Thomas Liquard is presenting at the 26th Annual ROTH Conference in Laguna Nigel, with the presentation webcast at: http://wsw.com/webcast/roth28/acl.ax.

Monday, March 3, 2014

Here we provide the slides that Thomas Liquard, CEO, will present at the 34th Annual Cowen & Co. Health Care Conference held in Boston, MA.

Watch the Webcast at http://wsw.com/webcast/cowen16/acl.ax

Monday, February 17, 2014

The Company has provided a short investor update presentation on the quarterly sales and profit share for fondaparinux from Dr Reddy's Laboratory.

Monday, January 13, 2014

Charles Walker, CEO, provides an update to investors on fondaparinux, HA-Irinotecan and the oncology portfolio.

Thursday, November 28, 2013

CEO Charles Walker provides an update on the sales of fondaparinux in his latest investor update

Thursday, September 19, 2013

Pages